Effect of CD34+cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation-Reference-Cited by-同舟云学术

Effect of CD34+cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

Published:2007-01 Issue:1 Volume:78 Page:21-28
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Klaus Jens,Herrmann Doris,Breitkreutz Iris,Hegenbart Ute,Mazitschek Uta,Egerer Gerlinde,Cremer Friedrich W.,Lowenthal Ray M.,Huesing Johannes,Fruehauf Stefan,Moehler Thomas,Ho Anthony D.,Goldschmidt Hartmut

Publisher

Wiley

Subject

Hematology,General Medicine

Reference29 articles.

1. Transplantation for multiple myeloma: who, when, how often?

2. High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation

3. Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience

4. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

5. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery;Cancers;2024-05-13

2. Understanding the impact of feedback regulations on blood cell production and leukemia dynamics using model analysis and simulation of clinically relevant scenarios;Applied Mathematical Modelling;2024-05

3. The effect of mobilizing large numbers of CD34 + cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation;Transfusion and Apheresis Science;2023-12

4. Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature;Indian Journal of Cancer;2023-10

5. MCQs on Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature;Indian Journal of Cancer;2023-10